Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Apogee Research, LLC Arlington VA 22203 USA

UEI: SLED_C16C792AB361E8F9

Apogee Research, LLC Arlington VA 22203 USA is a federal contractor, registered under UEI SLED_C16C792AB361E8F9. It has been awarded $6,587,472 in federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include FA8750 Afrl Rik and Niwc Atlantic.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_C16C792AB361E8F9

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with Apogee Research, LLC Arlington VA 22203 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for Apogee Research, LLC Arlington VA 22203 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in Apogee Research, LLC Arlington VA 22203 USA's top NAICS codes and agencies

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) open continuously until September 30, 2027. This competitive solicitation seeks innovative commercial products, technologies, and services to modernize the Organic Industrial Base (OIB) for Watervliet Arsenal and Benet Laboratories. The primary objective is to integrate manufacturing resources across the enterprise, focusing on linking legacy analogue systems with digital systems, expanding modeling and simulation, and improving the delivery of materiel to soldiers. The CSO is structured around specific Areas of Interest (AoIs) that address diverse needs, including advanced cannon technology, electronic access control systems, electrical infrastructure improvements, automated manufacturing for cannon components, and facility conversions. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final request for a Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Eligible participants include traditional and non-traditional business entities, including small businesses and foreign-owned businesses, provided they maintain an active SAM registration and a Unique Entity ID. All submissions must remain unclassified and are evaluated individually against the specific requirements of the applicable Area of Interest.
W6QK Acc Wva

POSTED

about 5 hours ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
L-PBF Development of ODS Alloys for Recording Methane/Oxygen Combustion Properties
Solicitation # 80NSSC27946801Q
The NASA Shared Services Center is seeking capability statements for a project focused on the laser powder bed fusion (L-PBF) development of oxide dispersion strengthened (ODS) and burn-resistant nickel-based alloys, including GRX-810, GRX-810+, and GRX-900. The scope of work involves advanced process development and parameter optimization using an EOS M280 system to achieve a relative density of 99.9 percent or higher. Key requirements include the production of test coupons and representative components, the supply of at least 600 kg of GRX-810 powder, and strict adherence to NASA-STD-6030 for mechanical validation. All deliverables must be shipped to the Marshall Space Flight Center in Huntsville, Alabama. This procurement is being conducted as a commercial items or services acquisition under FAR Part 12, with NAICS code 541715. NASA intends to issue a sole source contract to North American Manufacturing Pros LLC under FAR 12.102(a); however, the agency is requesting capability statements from other interested organizations to determine if the procurement should be conducted on a competitive basis. Interested parties must submit their qualifications to the primary point of contact, Cara Craft, by October 22, 2026. The contract requires rigorous documentation, including real-time reporting of anomalies and full powder traceability certifications covering chemical composition and particle morphology.
NASA Shared Services Center

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking proposals for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent systemic infections in combat scenarios. The project aims to advance the technology to a Technology Readiness Level of 7 or 8, requiring the development of a working prototype, the execution of human clinical trials, and the successful submission for FDA approval or clearance. The final product must be individual, compact, waterproof, and maintain sterilization, with a preference for packaging that allows one-handed opening in low-light environments. This effort is being conducted under the prototype Other Transaction Authority 10 U.S.C. 4022, meaning it does not follow standard FAR-based procurement. To be eligible, offerors must be nontraditional defense contractors, small businesses, or provide significant cost-sharing. The estimated period of performance is 48 months, divided into three objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals will be evaluated based on technical capability, management capability, and cost, with payments processed electronically via Wide Area Workflow. All clinical research must comply with Good Laboratory, Manufacturing, and Clinical Practices, and be approved by relevant Institutional Review Boards and the USAMRDC Office of Human and Animal Research Oversight.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
Request for Information – Prophylactic Platform for Medical Countermeasures
Solicitation # W911SR27SPPFC
The Department of Defense, through the Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND) and the Accelerated Defense Pharmaceuticals (ADP) program, is issuing a Request for Information (RFI) under solicitation W911SR27SPPFC. The objective is to identify capable companies that can advance the development of prophylactic medical countermeasures (MCMs) using existing platform technologies. The program focuses on progressing these countermeasures through Phase I or Phase II clinical trials, with a goal of enabling interim fielding via Expanded Access Protocols or pre-Emergency Use Authorization. The anticipated period of performance is up to four years, with work primarily conducted at the contractor's facilities. Interested respondents must provide a comprehensive capability description, including technical approach, regulatory status with the FDA, cGMP manufacturing capabilities, and a development roadmap with rough order of magnitude cost estimates. Evaluation criteria for future selections will emphasize manufacturing process capability, product safety and efficacy, past FDA experience, and the plug-and-play nature of the platform across various pathogens. Submissions must be delivered as a single searchable PDF, featuring a specific cover page and a core capability description not exceeding four pages. All non-clinical and clinical data must be SEND and CDISC compliant, and manufacturing must adhere to cGMP standards to support an Investigational New Drug application through a Biologics License Application.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

in 29 days
View Details
NAICS: 541715
New
Federal
ARMY OPEN SOLICITATION (AOS)
Solicitation # W9128Z-25-S-A002
The Army Open Solicitation (AOS), solicitation number W9128Z-25-S-A002, is an indefinite open solicitation issued by the U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG) Digital Capability Contracting Center of Excellence. Its primary objective is to support all Army mission areas and maximize Army lethality by rapidly acquiring innovative commercial technologies, research and development solutions, and software acquisition pathway procurements. The AOS leverages a broad range of authorities, including FAR 6.102(d)(2), FAR 35.016 Broad Agency Announcements, and various 10 U.S.C. sections for prototypes and experimental procurements, as well as the Commercial Solutions Opening (CSO) process. Interested parties can engage through two primary methods: responding to Active Capability Gaps (ACG) or submitting proposals in response to specific Calls for Solutions. The award process generally follows a multi-phase approach consisting of a Solution Brief, a Live Pitch, and a final Solution Proposal. Evaluation is based on a hierarchy of Technical Merit, Viability, Feasibility and Desirability, and Schedule and Price. All submissions must be unclassified, and the government does not reimburse companies for costs incurred during the initial three phases of the solicitation process. Key administrative requirements include mandatory registration in the System for Award Management (SAM) and the use of the Wide Area Work Flow (WAWF) for invoicing. Security requirements mandate that all government data reside within the exclusive legal jurisdiction of the United States. Solution Briefs are strictly limited to five written pages in 12-point font or fifteen briefing slides and must be submitted as a single PDF document. While the overall AOS remains open in perpetuity until canceled, individual Calls for Solutions have specific, limited response windows.
W6QK Acc-Apg Contr Ctr

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
ACC-DTA Ground Maneuver Commercial Solutions Opening (CSO)
Solicitation # W912CH-26-S-0001
The ACC-DTA Ground Maneuver Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, is a streamlined acquisition initiative authorized under DFARS Subpart 212-70. Its primary objective is to rapidly procure innovative commercial products, services, and non-developmental items to enhance the development, integration, and sustainment of ground vehicle systems. The program utilizes a multi-phased competitive process—consisting of solution briefs, presentations, and commercial solution proposals—to expedite the delivery of critical technologies. Awards may be structured as fixed-price or fixed-price incentive fee contracts, utilizing FAR Part 12 Commercial Procedures or non-FAR agreements such as Other Transaction Authority (OTA) and Cooperative Agreements. The scope of the CSO is broad and evolves through various Areas of Interest (AoIs) active through 2028. Key initiatives include the TIGER Readiness and Hackathon programs focused on supply chain resilience and advanced manufacturing for the Abrams Main Battle Tank's AGT 1500 engine, the FALCONS rapid prototyping effort for long-range sensors with an anticipated funding ceiling of 24 million dollars, and the procurement of Counter-Unmanned Aircraft Systems (C-UAS) detection and Mobile Camouflage Systems. Vendors must be registered in the System for Award Management (SAM) with a Unique Entity ID and a verified CAGE code. Evaluation is based on technical approach, performance schedule realism, and price affordability, with a strong emphasis on domestic sourcing compliance and adherence to quality standards such as ISO 9001 and AS9100.
W6QK Acc- Dta

POSTED

1 day ago

DEADLINE

in about 2 years
View Details
NAICS: 541715
New
Grant
Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)
Solicitation # PAR-28-093
Notice of Funding Opportunity PAR-28-093 is an R34 Planning Grant issued by the National Institutes of Health under the Department of Health and Human Services. The program supports pilot and feasibility studies designed to inform the design and conduct of future efficacy, effectiveness, and services research trials. Eligible research topics include the development of interventions to prevent substance use and substance use disorder, research into prevention, treatment, and recovery services for comorbid pain and mental health disorders, and HIV eradication research focusing on implementation science and recovery within substance use populations. The maximum project period is three years with total direct costs not to exceed 450,000 dollars. Applications are evaluated through the NIH peer review system based on scientific and technical merit, with a primary focus on the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Awardees are required to submit annual Research Performance Progress Reports and must adhere to strict cybersecurity incident reporting guidelines, including notifying HHS agencies within 48 hours of a discovery. Eligible applicants must maintain active registrations in the System for Award Management and eRA Commons.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in over 2 years
View Details